Analytical Data
-
Gene name
SLAMF9
- Application
-
Alternative Names
SLAMF9；CD2F10；SLAM family member 9
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96A28
-
Expression Region
1-289aa
-
AA Sequence
MCAFPWLLLLLLLQEGSQRRLWRWCGSEEVVAVLQESISLPLEIPPDEEVENIIWSSHKSLATVVPGKEGHPATIMVTNPHYQGQVSFLDPSYSLHISNLSWEDSGLYQAQVNLRTSQISTMQQYNICVYRWLSEPQITVNFESSGEGACSMSLVCSVEKAGMDMTYSWLSRGDSTYTFHEGPVLSTSWRPGDSALSYTCRANNPISNVSSCPIPDGPFYADPNYASEKPSTAFCLLAKGLLIFLLLVILAMGLWVIRVQKRHKMPRMKKLMRNRMKLRKEAKPGSSPA
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLAMF9, or SLAM family member 9, is a protein that plays a significant role in the immune response, particularly in the regulation of T cells and dendritic cells. It is part of the signaling lymphocyte activation molecule (SLAM) family, which is crucial for immune signaling and interaction between immune cells. The study of SLAMF9 has gained attention due to its potential implications in autoimmune diseases, infectious diseases, and cancer immunotherapy. Understanding the structure and function of SLAMF9 can provide insights into its mechanism of action and its interactions with various immune cells. Researchers have explored the recombinant production of SLAMF9 protein to investigate its biological activities, receptor-ligand interactions, and potential as a therapeutic target. The recombinant protein allows for the development of specific antibodies and assays that can aid in elucidating the signaling pathways involving SLAMF9. Additionally, studying SLAMF9 can enhance the understanding of its role in enhancing or suppressing immune responses, potentially leading to novel strategies in manipulating the immune system for therapeutic purposes. As research progresses, the characterization of SLAMF9 and its interactions may open up new avenues in targeted therapies for diseases where immune modulation is crucial.
